ERC funds to help predict drug responses

Johannes Zuber, IMP group leader.

An ERC Proof of Concept Grant has been awarded to IMP Group Leader Johannes Zuber. He will use the funds towards the development of a diagnostic platform for probing drug responses in cancer cells.